Alpha 2.0
Login Register
» Articles » PMID: 8549275

Quo Vadis with Bacterial Resistance?

Overview
Journal Drugs
Specialty Pharmacology
Date 1995 Jan 1
PMID 8549275
Citations 1
Authors
J D Williams
Affiliations
Soon will be listed here.
Citing Articles

A reappraisal of quinolone tolerability. The experience of their musculoskeletal adverse effects.

Hayem G, Carbon C Drug Saf. 1995; 13(6):338-42.

PMID: 8652078 DOI: 10.2165/00002018-199513060-00003.

References
1.
Livermore D, Williams R, Lindridge M, Slack R, Williams J . Pseudomonas aeruginosa isolates with modified beta-lactamase inducibility: effects on beta-lactam sensitivity. Lancet. 1982; 1(8287):1466-7. DOI: 10.1016/s0140-6736(82)92474-6. View
2.
Diver J, Schollaardt T, Rabin H, Thorson C, Bryan L . Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy. Antimicrob Agents Chemother. 1991; 35(8):1538-46. PMC: 245215. DOI: 10.1128/AAC.35.8.1538. View
3.
HANSMAN D, Glasgow H, Sturt J, Devitt L, Douglas R . Pneumococci insensitive to penicillin. Nature. 1971; 230(5293):407-8. DOI: 10.1038/230407a0. View
4.
Jacobs M, Koornhof H, Robins-Browne R, Stevenson C, Vermaak Z, Freiman I . Emergence of multiply resistant pneumococci. N Engl J Med. 1978; 299(14):735-40. DOI: 10.1056/NEJM197810052991402. View
5.
Appelbaum P . Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992; 15(1):77-83. DOI: 10.1093/clinids/15.1.77. View